Metrics to compare | ADPT | Sector Sector - Average of metrics from a broad group of related Consumer Non-Cyclicals sector companies | Relationship RelationshipADPTPeersSector | |
|---|---|---|---|---|
P/E Ratio | 0.0x | −2.5x | 10.5x | |
PEG Ratio | 0.00 | −0.05 | 0.03 | |
Price/Book | 0.0x | 1.7x | 1.5x | |
Price / LTM Sales | 0.0x | 1.3x | 0.8x | |
Upside (Analyst Target) | - | 315.3% | 24.9% | |
Fair Value Upside | Unlock | −2.5% | 16.1% | Unlock |
Adaptogenics Health Corp., a science led company, focuses on identifying, acquiring, designing, and advancing proprietary peptide and small molecule programs. The company is focusing on evaluating opportunities in metabolic health, muscle preservation, mitochondrial biology and inflammation, including delivery technologies intended to enhance the performance of promising molecules. It is also involved in the nutraceutical operations evaluating GLP 1 companion products intended to address challenges associated with medical weight loss, including muscle loss, nutritional deficiencies, and reduced physical function. Adaptogenics Health Corp. was incorporated in 2021 and is headquartered in Vancouver, Canada.